Roughly Speaking: Police and protests, Monday's debate, and 'Drunk History'
The Baltimore Sun

Amgen agrees to acquire Onyx

Robert A. Bradway, chairman and chief executive of Amgen Inc., reached a deal for Onyx Pharmaceuticals Inc. and its prized cancer drug, Kyprolis.
Matt Petit/Feature Photo Service
Copyright © 2016, The Baltimore Sun, a Baltimore Sun Media Group publication | Place an Ad
54°